Trader consensus reflects an 88.5% implied probability for no new pandemic in 2026, driven by the absence of sustained human-to-human transmission in leading candidates like avian influenza A(H5N1) and mpox clade Ib, per latest WHO and CDC surveillance data through March 2026. H5N1 remains widespread in wild birds and U.S. dairy cattle but shows only sporadic human cases—75 confirmed in the Americas since 2022, with no evidence of efficient person-to-person spread—while mpox cases total over 179,000 globally since 2022, mostly confined to sexual networks and African hotspots without escalating to pandemic thresholds. Enhanced post-COVID global monitoring, including WHO's multi-country situation reports, has contained threats, underscoring epidemiological baselines where true pandemics require novel pathogens with high transmissibility and severity. Upcoming CDC flu updates and WHO briefings could refine this outlook amid inherent forecasting uncertainties.